1020 related articles for article (PubMed ID: 10131343)
21. Upgrading quality assurance for pharmacy-prepared sterile products.
Zellmer WA
Am J Hosp Pharm; 1991 Nov; 48(11):2387-8. PubMed ID: 1746571
[No Abstract] [Full Text] [Related]
22. Prevalence, determinants, and characteristics of extemporaneous compounding in Jordanian pharmacies.
AlKhatib HS; Jalouqa S; Maraqa N; Ratka A; Elayeh E; Al Muhaissen S
BMC Health Serv Res; 2019 Nov; 19(1):816. PubMed ID: 31703672
[TBL] [Abstract][Full Text] [Related]
23. Quality assurance: ensuring pharmacy personnel follow procedures for handling cytotoxic drugs.
Scott BE; White SJ; Matthews T
Hosp Pharm; 1987 Jan; 22(1):45-9. PubMed ID: 10280293
[TBL] [Abstract][Full Text] [Related]
24. Practices of pharmacies that compound extemporaneous formulations.
Treadway AK; Craddock D; Leff R
Am J Health Syst Pharm; 2007 Jul; 64(13):1403-9. PubMed ID: 17592006
[TBL] [Abstract][Full Text] [Related]
25. End-preparation assessments and tests for compounded sterile preparations.
McElhiney LF
Int J Pharm Compd; 2013; 17(4):307-11. PubMed ID: 24261146
[TBL] [Abstract][Full Text] [Related]
26. The role of policy in community pharmacies' response to injection-drug use: results of a nationwide Canadian survey.
Myers T; Cockerill R; Millson M; Rankin J; Worthington C
AIDS Public Policy J; 1996; 11(2):78-88. PubMed ID: 10915241
[TBL] [Abstract][Full Text] [Related]
27. Health care and hospital pharmacy in Denmark.
Nedergaard M
Am J Hosp Pharm; 1977 Jun; 34(6):595-600. PubMed ID: 879180
[TBL] [Abstract][Full Text] [Related]
28. Impact of United States Pharmacopeia chapter 797: results of a national survey.
Candy TA; Schneider PJ; Pedersen CA
Am J Health Syst Pharm; 2006 Jul; 63(14):1336-43. PubMed ID: 16809754
[TBL] [Abstract][Full Text] [Related]
29. Compounding pharmacy conundrum: "we cannot live without them but we cannot live with them" according to the present paradigm.
Guharoy R; Noviasky J; Haydar Z; Fakih MG; Hartman C
Chest; 2013 Apr; 143(4):896-900. PubMed ID: 23412546
[TBL] [Abstract][Full Text] [Related]
30. A compounding compliance team at an academic medical center.
Chaffee BW; Tharp JC; Clark JS; Kent S
Am J Health Syst Pharm; 2020 May; 77(11):882-891. PubMed ID: 32318700
[TBL] [Abstract][Full Text] [Related]
31. [Implementation of hygiene procedures, microbial and physical controls and environmental monitoring in radiopharmacy department].
Duez C; Pons-Kerjean N; Paycha F; Callanquin M
Ann Pharm Fr; 2009 Nov; 67(6):419-26. PubMed ID: 19900606
[TBL] [Abstract][Full Text] [Related]
32. Compounding pharmacies: who is in charge?
Pergolizzi JV; Labhsetwar S; LeQuang JA
Pain Pract; 2013 Mar; 13(3):253-7. PubMed ID: 23350709
[TBL] [Abstract][Full Text] [Related]
33. Adventures in the Environmental World and Environmental Microbiology Sampling of Air for Pharmaceutical Sterile Compounding.
Ligugnana R
Int J Pharm Compd; 2017; 21(3):182-190. PubMed ID: 28557779
[TBL] [Abstract][Full Text] [Related]
34. Draft technical assistance bulletin on quality assurance for pharmacy-prepared sterile products. American Society of Hospital Pharmacists, Council on Professional Affairs.
Am J Hosp Pharm; 1993 Jul; 50(7):1440-52. PubMed ID: 8362882
[No Abstract] [Full Text] [Related]
35. Survey of pharmacotherapy monitoring in Canadian acute care hospitals.
Einarson TR; Mann JL
Can J Hosp Pharm; 1989 Dec; 42(6):229-34. PubMed ID: 10296655
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive intravenous admixture services: logistics and quality assurance in a university affiliated teaching institution.
Wellman GS; Hale KM; Schneider PJ; Hale KN
Hosp Pharm; 1984 Sep; 19(9):601-6. PubMed ID: 10267935
[TBL] [Abstract][Full Text] [Related]
37. [Recommendations for the safety preparation of sterile medicines in medical wards].
Martín de Rosales Cabrera AM; López Cabezas C; Pernía López MS; Dávila Pousa C; Vila Clérigues MN; Alonso Herreros JM; García Salom P; Lozano Blázquez A
Farm Hosp; 2014 Jan; 38(1):57-64. PubMed ID: 24483861
[TBL] [Abstract][Full Text] [Related]
38. Precautions followed by personnel involved with the preparation of parenteral antineoplastic medications.
Tortorici MP
Hosp Pharm; 1980 Jun; 15(6):293, 295-6, 298-9 passim. PubMed ID: 10247268
[TBL] [Abstract][Full Text] [Related]
39. Compounding practices in Iran.
Goodarzi N; Niknam S; Akbarzadeh T; Gholami K
Int J Pharm Compd; 2014; 18(2):112-6. PubMed ID: 24881113
[TBL] [Abstract][Full Text] [Related]
40. Quality assurance for pharmacy-prepared sterile products in hospitals and home infusion facilities.
Klein C
Am J Health Syst Pharm; 1996 Nov; 53(21):2581. PubMed ID: 8913385
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
